Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pear Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics's Return On Capital Employed Insights
Via Benzinga
Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series
From Pear Therapeutics, Inc.
Via Business Wire
California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States
From Pear Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP
From Pear Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  Thursday's session saw 329 companies set new 52-week lows. 
Via Benzinga
Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference
From Pear Therapeutics, Inc.
Via Business Wire
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Pear Therapeutics Reports Third Quarter 2022 Results
From Pear Therapeutics, Inc.
Via Business Wire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Pear Therapeutics to Participate in the BTIG Digital Health Forum
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe
From Pear Therapeutics, Inc.
Via Business Wire
State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022
From Pear Therapeutics, Inc.
Via Business Wire
Avis Budget, Scholastic And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Pear Therapeutics Announces Publication of Real-World Data Showing High Rates of Engagement, Retention and Abstinence with reSET®
From Pear Therapeutics, Inc.
Via Business Wire
Netflix, Intuitive Surgical And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning! 
Via InvestorPlace
Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket
Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. 
Via Benzinga
Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.